garden-city
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
March 26, 2016 by publisher · Leave a Comment
SAN JOSE, Calif.,/NEW YORK (Reuters) – A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C. The damages award is far less than the $2 billion Merck had demanded. On Tuesday, the same jury in San Jose, California, upheld the validity of the patents, which
Here is the original post:
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
garden-city
Microsoft told potential Yahoo bidders it might back bids: report
March 26, 2016 by admin · Leave a Comment
(Reuters) – Microsoft Corp executives are in talks with equity firms considering bids for Yahoo Inc! saying that Microsoft might be willing to offer “significant financing” for their efforts, tech news site Recode reported on Thursday. Microsoft's move is an attempt to ensure a good relationship with Yahoo's buyer, the website reported. Yahoo launched an auction of its core
More here:
Microsoft told potential Yahoo bidders it might back bids: report